FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169201700> ?p ?o ?g. }

• W2169201700 endingPage "7135" @default.
• W2169201700 startingPage "7127" @default.
• W2169201700 abstract "ABSTRACT The neutralizing activities of anti-V3 antibodies for HIV-1 isolates is affected both by sequence variation within V3 and by epitope masking by the V1/V2 domain. To analyze the relative contribution of V3 sequence variation, chimeric Env genes that contained consensus V3 sequences from seven HIV-1 subtypes in the neutralization-sensitive SF162 Env backbone were constructed. Resulting viral pseudotypes were tested for neutralization by 15 anti-V3 MAbs isolated from humans infected with viruses of either subtype B (anti-V3 B MAbs) or subtype A (anti-V3 A MAbs). Pseudovirions with the subtype B consensus V3 sequence were potently neutralized (IC 50 < 0.006 μg/ml) by all but one of these MAbs, while pseudovirions with V3 subtypes A, C, F, H, AG, and AE were generally neutralized more effectively by anti-V3 A MAbs than by anti-V3 B MAbs. A V1/V2-masked Env version of SF162 Env with the consensus B V3 sequence was also neutralized by these MAbs, although with considerably lower potency, while similarly masked chimeras with V3 sequences of subtype A, C, or AG were weakly neutralized by anti-V3 A MAbs but not by anti-V3 B MAbs. Mutations in the V1/V2 domain of YU-2 Env increased the sensitivity of this highly resistant Env to a pool of anti-V3 B MAbs several thousand-fold. These results demonstrated (i) the exceptional sensitivity of representative V3 domains of multiple subtypes to neutralization in the absence of epitope masking, (ii) the broader neutralizing activity of anti-V3 A MAbs for viruses containing diverse V3 sequences, and (iii) the generality and dominant effect of V1/V2 masking on restriction of V3-mediated neutralization." @default.
• W2169201700 created "2016-06-24" @default.
• W2169201700 creator A5027075998 @default.
• W2169201700 creator A5033634336 @default.
• W2169201700 creator A5035006967 @default.
• W2169201700 creator A5039853127 @default.
• W2169201700 creator A5041332295 @default.
• W2169201700 creator A5075678687 @default.
• W2169201700 date "2006-07-15" @default.
• W2169201700 modified "2023-09-24" @default.
• W2169201700 title "Factors Determining the Breadth and Potency of Neutralization by V3-Specific Human Monoclonal Antibodies Derived from Subjects Infected with Clade A or Clade B Strains of Human Immunodeficiency Virus Type 1" @default.
• W2169201700 cites W1482966474 @default.
• W2169201700 cites W1528520360 @default.
• W2169201700 cites W1554513767 @default.
• W2169201700 cites W1635348995 @default.
• W2169201700 cites W1794879226 @default.
• W2169201700 cites W1894176765 @default.
• W2169201700 cites W1938402363 @default.
• W2169201700 cites W1988015426 @default.
• W2169201700 cites W1995187084 @default.
• W2169201700 cites W1997677784 @default.
• W2169201700 cites W1998987175 @default.
• W2169201700 cites W2000564337 @default.
• W2169201700 cites W2020100193 @default.
• W2169201700 cites W2024977015 @default.
• W2169201700 cites W2029102196 @default.
• W2169201700 cites W2056493803 @default.
• W2169201700 cites W2068029401 @default.
• W2169201700 cites W2072901265 @default.
• W2169201700 cites W2073597533 @default.
• W2169201700 cites W2084341498 @default.
• W2169201700 cites W2090763940 @default.
• W2169201700 cites W2093282128 @default.
• W2169201700 cites W2099185347 @default.
• W2169201700 cites W2099576234 @default.
• W2169201700 cites W2122936417 @default.
• W2169201700 cites W2124445678 @default.
• W2169201700 cites W2124935744 @default.
• W2169201700 cites W2127682720 @default.
• W2169201700 cites W2128055354 @default.
• W2169201700 cites W2142732888 @default.
• W2169201700 cites W2145462968 @default.
• W2169201700 cites W2146704167 @default.
• W2169201700 cites W2157210912 @default.
• W2169201700 cites W2162465939 @default.
• W2169201700 cites W2165236706 @default.
• W2169201700 cites W2171992047 @default.
• W2169201700 doi "https://doi.org/10.1128/jvi.02619-05" @default.
• W2169201700 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1489036" @default.
• W2169201700 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16809318" @default.
• W2169201700 hasPublicationYear "2006" @default.
• W2169201700 type Work @default.
• W2169201700 sameAs 2169201700 @default.
• W2169201700 citedByCount "86" @default.
• W2169201700 countsByYear W21692017002012 @default.
• W2169201700 countsByYear W21692017002013 @default.
• W2169201700 countsByYear W21692017002014 @default.
• W2169201700 countsByYear W21692017002015 @default.
• W2169201700 countsByYear W21692017002016 @default.
• W2169201700 countsByYear W21692017002017 @default.
• W2169201700 countsByYear W21692017002018 @default.
• W2169201700 countsByYear W21692017002019 @default.
• W2169201700 countsByYear W21692017002020 @default.
• W2169201700 countsByYear W21692017002021 @default.
• W2169201700 countsByYear W21692017002022 @default.
• W2169201700 countsByYear W21692017002023 @default.
• W2169201700 crossrefType "journal-article" @default.
• W2169201700 hasAuthorship W2169201700A5027075998 @default.
• W2169201700 hasAuthorship W2169201700A5033634336 @default.
• W2169201700 hasAuthorship W2169201700A5035006967 @default.
• W2169201700 hasAuthorship W2169201700A5039853127 @default.
• W2169201700 hasAuthorship W2169201700A5041332295 @default.
• W2169201700 hasAuthorship W2169201700A5075678687 @default.
• W2169201700 hasBestOaLocation W21692017002 @default.
• W2169201700 hasConcept C14086860 @default.
• W2169201700 hasConcept C153911025 @default.
• W2169201700 hasConcept C159047783 @default.
• W2169201700 hasConcept C159654299 @default.
• W2169201700 hasConcept C195616568 @default.
• W2169201700 hasConcept C2522874641 @default.
• W2169201700 hasConcept C2779921545 @default.
• W2169201700 hasConcept C542903549 @default.
• W2169201700 hasConcept C54355233 @default.
• W2169201700 hasConcept C86803240 @default.
• W2169201700 hasConceptScore W2169201700C14086860 @default.
• W2169201700 hasConceptScore W2169201700C153911025 @default.
• W2169201700 hasConceptScore W2169201700C159047783 @default.
• W2169201700 hasConceptScore W2169201700C159654299 @default.
• W2169201700 hasConceptScore W2169201700C195616568 @default.
• W2169201700 hasConceptScore W2169201700C2522874641 @default.
• W2169201700 hasConceptScore W2169201700C2779921545 @default.
• W2169201700 hasConceptScore W2169201700C542903549 @default.
• W2169201700 hasConceptScore W2169201700C54355233 @default.
• W2169201700 hasConceptScore W2169201700C86803240 @default.
• W2169201700 hasIssue "14" @default.
• W2169201700 hasLocation W21692017001 @default.
• W2169201700 hasLocation W21692017002 @default.
• W2169201700 hasLocation W21692017003 @default.

• next